Cell wall disruption, membrane damage, and decrease in the expression of Yrp1 virulence factor in

Animals Anti-bacterial agents Gene expression Propolis Virulence factor Yersinia ruckeri

Journal

Iranian journal of microbiology

ISSN: 2008-3289

Titre abrégé: Iran J Microbiol

Pays: Iran

ID NLM: 101518404

Informations de publication

Date de publication:
Aug 2023

Historique:

medline: 4 12 2023

pubmed: 4 12 2023

entrez: 4 12 2023

Statut: ppublish

Résumé

Instead of antibiotics, propolis is a promising alternative for treating bacterial diseases. The aim of this study was to evaluate the effect of propolis ethanol extract (PEE) on The effect of propolis on the bacterial cell wall, membrane, and DNA using scanning electron microscopy (SEM) was investigated. Its effect on the NAD+/NADH ratio, reactive oxygen species (ROS) production, as well as the expression of a virulence factor (yrp1) was also determined. It was demonstrated that PEE has multiple antibacterial mechanisms against The obtained results indicated that the mode of propolis action against

Sections du résumé

Background and Objectives UNASSIGNED

Instead of antibiotics, propolis is a promising alternative for treating bacterial diseases. The aim of this study was to evaluate the effect of propolis ethanol extract (PEE) on

Materials and Methods UNASSIGNED

The effect of propolis on the bacterial cell wall, membrane, and DNA using scanning electron microscopy (SEM) was investigated. Its effect on the NAD+/NADH ratio, reactive oxygen species (ROS) production, as well as the expression of a virulence factor (yrp1) was also determined.

Results UNASSIGNED

It was demonstrated that PEE has multiple antibacterial mechanisms against

Conclusion UNASSIGNED

The obtained results indicated that the mode of propolis action against

Identifiants

DOI: 10.18502/ijm.v15i4.13507 PMID: 38045706 PMC: PMC10692965

pubmed: 38045706

doi: 10.18502/ijm.v15i4.13507

pii: IJM-15-533

pmc: PMC10692965

doi:

Types de publication

Journal Article

Langues

eng

Pagination

533-540

Informations de copyright

Références

Front Cell Infect Microbiol. 2016 Nov 08;6:145

pubmed: 27878107

J Ethnopharmacol. 2021 Apr 6;269:113662

pubmed: 33307049

Molecules. 2019 Jan 22;24(3):

pubmed: 30678237

J Chemother. 2000 Oct;12(5):390-5

pubmed: 11128558

Biotechnol Lett. 2013 Apr;35(4):631-7

pubmed: 23264268

Front Microbiol. 2018 May 25;9:1098

pubmed: 29887855

mBio. 2022 Jan 18;13(1):e0243421

pubmed: 35038918

Appl Microbiol Biotechnol. 2019 Apr;103(8):3521-3535

pubmed: 30852658

Caspian J Intern Med. 2020;11(2):191-198

pubmed: 32509248

Cell. 2007 Sep 7;130(5):797-810

pubmed: 17803904

Clin Infect Dis. 2020 Dec 3;71(9):e523-e529

pubmed: 32052041

Foods. 2022 Jul 10;11(14):

pubmed: 35885284

Pharmazie. 2013 Aug;68(8):695-701

pubmed: 24020127

Sci Rep. 2019 Aug 6;9(1):11364

pubmed: 31388043

Braz J Biol. 2020 Oct-Dec;80(4):934-942

pubmed: 32935820

BMC Complement Altern Med. 2019 Oct 11;19(1):266

pubmed: 31601198

Sci Rep. 2021 Dec 13;11(1):23860

pubmed: 34903790

Front Cell Infect Microbiol. 2018 Jun 26;8:218

pubmed: 29998086

Braz J Microbiol. 2010 Oct;41(4):1086-92

pubmed: 24031591

Microbiologyopen. 2016 Aug;5(4):597-603

pubmed: 27038237

BMC Vet Res. 2013 Oct 21;9:215

pubmed: 24144165

Lett Appl Microbiol. 2016 Feb;62(2):192-8

pubmed: 26643709

Appl Microbiol Biotechnol. 2012 Oct;96(2):511-20

pubmed: 22868827

Saudi J Biol Sci. 2020 Nov;27(11):3079-3086

pubmed: 33100868

Gut Pathog. 2022 Feb 22;14(1):10

pubmed: 35193669

Molecules. 2014 Nov 26;19(12):19610-32

pubmed: 25432012

Curr Drug Discov Technol. 2015;12(4):229-39

pubmed: 26416665

Adv Pharmacol Sci. 2013;2013:308249

pubmed: 24382957

J Appl Microbiol. 2017 Apr;122(4):911-920

pubmed: 28066967

Pharmaceutics. 2021 Nov 26;13(12):

pubmed: 34959303

Biomed Res Int. 2016;2016:4302706

pubmed: 27110563

Appl Environ Microbiol. 2003 Dec;69(12):7328-35

pubmed: 14660382

Medicines (Basel). 2018 Jan 03;5(1):

pubmed: 29301368